Director bought
A board member of TransDigm Group spent $1.3K of their very own money to buy TransDigm Group shares. 1 other person at TransDigm Group bought some too, in the same month.
Loading…
Traded Feb 6, 2026 · Filed Feb 9, 2026
The boss of TransDigm Group spent $1.22M of their very own money to buy TransDigm Group shares. 1 other person at TransDigm Group bought some too, in the same month. Their pile of TransDigm Group shares grew by 41%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$1,220,048
Shares × reported transaction price
$1M+
+41.1%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 3 months
Confirmed open-market purchases by the same insider in the available history
Yes
Compared with 6 earlier confirmed purchases
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
3 days after results of Feb 3, 2026, 67 days before results of Apr 14, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $1,285.53 on Feb 6, 2026, within 5% of its 52-week low, after a 2% drop over the previous 30 trading days
52-week range $1,231.75 (Apr 8, 2025) to $1,620.83 (Jul 30, 2025), 14% of the way up, from 251 adjusted closes. 30 trading days earlier: $1,314.52 on Dec 23, 2025. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | -0.8% | -1.3% | +0.6% |
| 30 days | -6.6% | -3.8% | -2.8% |
| 90 days | -8.6% | +6.8% | -15.4% |
| 180 days | -6.7% | +11.7% | -18.4% |
Past results only. Not a forecast.
A board member of TransDigm Group spent $1.3K of their very own money to buy TransDigm Group shares. 1 other person at TransDigm Group bought some too, in the same month.
Derivative exercise or conversion — not an open-market buy.
Derivative exercise or conversion — not an open-market buy.